In this week's Biotech Scorecard newsletter, Adam Feuerstein takes on the company touting gold microdust suspended in water ...

The Italian firm Angelini Pharma is buying Catalyst Pharmaceuticals, the maker of rare disease drugs, for $4.1 billion.

Scientists are worried that hantaviruses haven’t been as well studied as they ought to be, but not that the MV Hondius cruise ...

Eugene Braunwald, who was widely recognized as “ The Father of Modern Cardiology ,” died on April 22 at the age of 96. When I ...

WASHINGTON — After defending the Trump administration’s dramatic health cuts as a solution to bureaucratic bloat, the health department’s leaders are beginning to realize that a demoralized, ...

The analysis estimated the drug companies’ pledge to offer all new drugs at most-favored nation pricing would save the U.S.

Sanofi has asked the FDA to pull its type 1 diabetes drug out of Commissioner Marty Makary’s new speedy drug review program.

Marty Makary says he was "skeptical initially" about flavored vapes but that age-gating technology could limit their use.

Faced with stiff local opposition and a possible loss in court, PeaceHealth drops plan to replace Eugene Emergency Physicians ...

In this edition of AI Prognosis, Brittany Trang raises the question: What kind of health data would we need to train AI ...

Cell and gene therapy makers met in Rome to discuss the field's outlook in Europe. One main topic of conversation: the FDA.

According to CDC data, just over 13% of adults have reported using an anti-depressant. Last year, HHS released a report ...